Package 16729-046-17

{"route": ["ORAL"], "spl_id": "40828d2e-69eb-5d38-e063-6394a90abd70", "openfda": {"unii": ["48A5M73Z4Q"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_set_id": ["4e06b20d-cc5d-46eb-991b-5972248de3af"], "manufacturer_name": ["Accord Healthcare Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (16729-046-15)", "package_ndc": "16729-046-15", "marketing_start_date": "20210713"}, {"sample": false, "description": "1000 TABLET, FILM COATED in 1 BOTTLE (16729-046-17)", "package_ndc": "16729-046-17", "marketing_start_date": "20180806"}], "brand_name": "ATORVASTATIN CALCIUM", "product_id": "16729-046_40828d2e-69eb-5d38-e063-6394a90abd70", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["HMG-CoA Reductase Inhibitor [EPC]", "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "product_ndc": "16729-046", "generic_name": "ATORVASTATIN CALCIUM", "labeler_name": "Accord Healthcare Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ATORVASTATIN CALCIUM", "active_ingredients": [{"name": "ATORVASTATIN CALCIUM TRIHYDRATE", "strength": "40 mg/1"}], "application_number": "ANDA207687", "marketing_category": "ANDA", "marketing_start_date": "20180806", "listing_expiration_date": "20261231"}